How A Radical New Vaccine Could Eradicate This Deadly Disease By 2040 About 40 million children born every year in malaria areas in Africa would benefit from a vaccine. Inverse · Nov 10, 2023
Peace Corps settles negligence lawsuit with suburban Chicago family for $750,000 Bernice Heiderman, a University of Illinois Chicago grad, died after contracting malaria while serving in East Africa. A Peace Corps doctor never tested her for the treatable illness. Chicago Sun-Times · Nov 8, 2023
Kenya manufacturer is first in Africa to get WHO approval for malaria drug Pre-qualification seen as significant step towards self-sufficiency in healthcare in continent where more than 70% of drugs are imported The Guardian - UK · Nov 7, 2023
Amazon a time bomb for the emergence of diseases with pandemic potential – due to deforestation and climate change Home to the greatest biodiversity on the planet, the Amazon is also a ticking time bomb for the emergence or resurgence of diseases with pandemic potential. This is because environmental degradation and altered landscapes are important factors in this process, which are exacerbated during periods of extreme drought, such as… The Conversation · Nov 2, 2023
On Halloween, here's how to dress up as earth's scariest critter — with minimal prep It's not a shark. It's not a lion. It's not a snake. And all you'll need is some pipe cleaners, sunglasses and gossamer wings. WEKU · Oct 28, 2023
This new malaria vaccine will transform our battle with the deadliest creatures on Earth Malaria has re-emerged in my home state of Florida, and will spread further thanks to climate change, says Devi Sridhar, chair of global public health at the University of Edinburgh The Guardian - UK · Oct 26, 2023
Two hostages freed by Hamas as talks break down to release 50 more IN THE PRESS – Tuesday, October 24: We take a look at press reaction to two more hostages being released by Hamas, as well as the US and EU disagreeing on the need for a ceasefire. Also, the Washington Post has a long read on the spread of malaria. Finally,… France 24 · Oct 24, 2023
Breakthroughs in medicine: top virologist on the two most important developments for Africa There have been several important breakthroughs in medical science recently. Crispr, mRNA, next-generation cancer treatments and game-changing vaccines are some of them. Oyewale Tomori, a virologist with decades-long involvement in managing diseases in Nigeria, gives his verdict on the most significant discoveries and what they mean for Africa. The Conversation · Oct 23, 2023
Mosquito-borne illness reaches U.S. soil Climate change and urbanization is spreading dengue and malaria across the U.S. and Europe. Can we brace ourselves? Salon · Oct 21, 2023
Traditional Chinese Medicine Holds Potential As Treatment For Osteoporosis Antimalarial drug derived from Chinese medicine reverses bone loss in mice, offering hope for osteoporosis treatment. Zenger · Oct 18, 2023
Science This Week | 2023 Nobel Prize winners announced, ISRO to begin unmanned flight tests for Gaganyaan and more Check out The Hindu’s science wrap featuring top 7 stories on new discoveries, findings, and studies in the scientific world from this week. The Hindu · Oct 8, 2023
Now a more efficacious, inexpensive malaria vaccine Oxford University develops R21/MatrixM malaria vaccine; WHO recommends it; 3 countries approve; efficacy 75-79% in 5-17 mth olds; booster restores efficacy; cheaper than RTS,S/AS01. The Hindu · Oct 7, 2023
Locally acquired malaria case found in Arkansas The new case brings the number of malaria cases in the US this year to 15 The Independent UK · Oct 6, 2023
Big Pharma slowed vaccine development A vaccine against tuberculosis has never been closer to reality. But development slowed due to corporate interests Salon · Oct 5, 2023
The Conversation · Oct 5, 2023 New malaria vaccine: no silver bullet but an important step towards eradication In what was very big news for global health, this week the World Health Organisation (WHO) recommended a new vaccine for the prevention of malaria in children, called R21/Matrix-M.
The Hindu · Oct 4, 2023 Why is the R21/Matrix malaria vaccine being called ‘revolutionary’? | Explained The R21/Matrix malaria vaccine is 75% effective in reducing episodes over a year, can be manufactured at scale, and is cost-effective. It has the potential to reduce the burden of malaria in Africa and beyond.
The Guardian - UK · Oct 4, 2023 The new malaria vaccine will prevent many deaths – but it’s by no means the end of the disease The new R21/Matrix-M vaccine will be far more easily available than the first vaccine – but the reality of life in Africa will blunt its impact
WEKU · Oct 3, 2023 A 'dream' come true: Now there are 2 vaccines to slash the frightful toll of malaria The head of the World Health Organization, Tedros Adhanom Ghebreyesus.Tedros, says he used to "dream of the day when we would have a ... vaccine against malaria. Now, we have two."
The Conversation · Oct 3, 2023 'We could eradicate malaria by 2040' says expert after revolutionary vaccine is approved by WHO The World Health Organization has approved a new vaccine that scientists argue will be a game-changer in the fight against malaria, which kills half a million people in Africa every year. Trials have shown that the R21/Matrix vaccine, developed by Oxford University together with the Serum Institute of India, reduces…
The Guardian - UK · Oct 3, 2023 The Guardian view on malaria vaccines: life-saving tools that are sorely needed Editorial: Deaths from the disease have risen in recent years, but the toll can and must be cut through a variety of measures
The Conversation · Oct 3, 2023 The long road to a new malaria vaccine, told by the scientists behind the breakthrough – podcast The world has waited decades for a malaria vaccine, and now two have come along in quick succession. On October 2, the World Health Organization (WHO) recommended that a new malaria vaccine, R21, developed by the University of Oxford be rolled out for the prevention of malaria in children, just…
Dynamite News · Oct 3, 2023 WHO recommends Malaria vaccine made by Oxford University and Serum Institute of India To date, the R21/Matrix-M malaria vaccine has been licensed for use in Ghana, Nigeria and Burkina Faso. Read further on Dynamite News
The Independent UK · Oct 2, 2023 Major step in fight against malaria as Oxford-developed vaccine approved by WHO It is estimated that around 500,000 children die of malaria each year
The Hindu · Oct 2, 2023 Oxford-Serum institute malaria vaccine recommended for use by WHO WHO recommends R21/Matrix-M malaria vaccine developed by Oxford and Serum Institute of India. Vaccine has met safety, quality and effectiveness standards. Serum Institute has established production capacity for 100 million doses/annum. Vaccine efficacy over 12 months is 75% at sites with high seasonal malaria transmission and 68% at sites with…
The Guardian - UK · Oct 2, 2023 Cheaper, more effective malaria vaccine wins WHO approval R21/Matrix-M vaccine, developed by the University of Oxford, is the first malaria vaccine to reach 75% efficacy target